Finerenone Potassium Threshold — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Consistently normal serum potassium concentration before initiation
KDIGO 2024 practice point 3.8.3 states: to mitigate risk of hyperkalaemia, select people with consistently normal serum potassium concentration and monitor serum potassium regularly after initiation of a nonsteroidal MRA. In the FIDELIO and FIGARO trials, potassium had to be ≤4.8 mmol/L at randomisation. A potassium of 5.4 mmol/L would need to be corrected first (dietary measures, potassium binder if needed) before safely starting Finerenone.
Reference: KDIGO 2024 – CKD Guideline; FIDELIO-DKD/FIGARO-DKD